Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surgery in Focally Progressive GIST
NCT03862768Unknown
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Jul 2019
- Primary completion
- Jun 2021
01
Overview
Randomised, open-label trial in gastrointestinal stromal tumor (GIST) (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Progression-free Survival at 1 year. Status: unknown.
02
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT03862768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03862768.